Anti-tumor effect and mechanisms of shikonin on gliomas

doi:10.3760/cma.j.issn.1673-422X.2019.08.009

Journal of International Oncology ›› 2019, Vol. 46 ›› Issue (8): 489-491.doi: 10.3760/cma.j.issn.1673-422X.2019.08.009

Previous Articles Next Articles

Anti-tumor effect and mechanisms of shikonin on gliomas

Yi Lin¹, Qiu Shi²

¹Department of Geriatric Medicine, General Hospital of Jilin Chemical Industry Group of Jilin City of Jilin Province, Jilin 132021, China; ²Department of Radiotherapy and Chemotherapy, General Hospital of Jilin Chemical Industry Group of Jilin City of Jilin Province, Jilin 132021, China

Received:2019-05-09 Revised:2019-05-16 Online:2019-08-08 Published:2019-10-31
Contact: Qiu Shi E-mail:qiushi555@163.com

Abstract

Abstract: Shikonin has anti-tumor activity, and it not only can inhibit the proliferation, migration and infiltration of glioma cells, but also induce necroptosis of glioma cells via promoting the production of reactive oxygen species. Shikonin combined with endoplasmic reticulum stress inhibitors or regulatory tactics of micro-RNA expression may further enhance its killing effect on gliomas. Shikonin armed by nanoparticles shows increased targetability to gliomas. Shikonin combined with tumor-targeted therapeutic drugs or chemotherapeutic drugs is expected to overcome the drug resistance of glioma cells.

Key words: Gliomas, Shikonin, Reactive oxygen species, Antineoplastic agents, Necroptosis

Yi Lin, Qiu Shi. Anti-tumor effect and mechanisms of shikonin on gliomas[J]. Journal of International Oncology, 2019, 46(8): 489-491.

[1]	Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358.
[2]	Wang Zihao, Wang Yu, Yang Xin, He Yi, Mo Xingkui, Yuan Tao. Research progress on the molecular mechanism and related treatments of ferroptosis in osteosarcoma [J]. Journal of International Oncology, 2024, 51(4): 239-244.
[3]	Liu Xiaojie, Huang Junxing. Research progress of NADPH oxidase 2 in malignant tumors [J]. Journal of International Oncology, 2023, 50(10): 618-621.
[4]	Wang Liwei, Liang Hongsheng, Du Songlin, Chen Zhihao, Wang Qing, Gao Aili. Research progress of avermectins in anti-tumor [J]. Journal of International Oncology, 2022, 49(6): 353-356.
[5]	Xiao Nan, Sun Pengfei. Research progress of oxidative stress in the sensitivity of chemoradiotherapy for gliomas [J]. Journal of International Oncology, 2022, 49(6): 357-361.
[6]	Yang Ya, Ning Xiaofei, Li Bingliang, Yao Hui, Shan Changping, Lyu Min. Study on the mechanism of procyanidin mediated anti gastric cancer SNU-1 cell line by inducing the production of reactive oxygen species [J]. Journal of International Oncology, 2022, 49(5): 257-262.
[7]	Zhang Yongli, Zhang Ruojia, Fan Huancai, Ge Luna, Wang Lin. TXNDC5-Prx2 axis regulates drug resistance of prostate cancer cells [J]. Journal of International Oncology, 2021, 48(8): 473-478.
[8]	Xu Yiyue, Zhao Shaorong, Liu Jingjing, Zhang Jin. Mechanisms of ferroptosis and its significance in breast cancer therapy [J]. Journal of International Oncology, 2020, 47(6): 372-376.
[9]	Yang Yiting, Cheng Zhongping. The role of inflammatory cytokines in chemoresistance of epithelial ovarian cancer [J]. Journal of International Oncology, 2020, 47(4): 249-251.
[10]	Wang Shuang, Tang Yunyun, Yue Qi. New progress in antitumor research of non-psychoactive cannabidiol [J]. Journal of International Oncology, 2020, 47(10): 619-623.
[11]	Liang Jing1,3, Han Sha2, Yao Jing3, Kong Qingsheng2. Effect of histone deacetylase and its inhibitor on tumor [J]. Journal of International Oncology, 2019, 46(4): 235-238.
[12]	Xiong Bobo, Zhang Jinsong, Li Ning, Wang Haifeng, Zuo Yigang, Wang Jiansong. Molecular targeted therapy for advanced kidney cancer [J]. Journal of International Oncology, 2019, 46(12): 705-710.
[13]	Song Jiarui, Zhang Bin, Yang Zhongwen, Xu Baocai, Wang Chao, Ma Ming. Research progress of new antioxidants in urological neoplasms [J]. Journal of International Oncology, 2019, 46(1): 54-56.
[14]	Wang Gang, Wang Huangzhen, Xue Ting. Effect of oxaliplatin induced autophagy on drug resistance of SGC7901 gastric cancer cells [J]. Journal of International Oncology, 2018, 45(8): 513-518.
[15]	Ling Xiaofei, Xu Ke, Shao Hua, Wang Cuijuan. Anticancer mechanism and application of curcumin analog EF24 [J]. Journal of International Oncology, 2018, 45(3): 172-175.

Anti-tumor effect and mechanisms of shikonin on gliomas

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments